Prevalence and clinical course of viral upper respiratory tract infections in immunocompromised pediatric patients with malignancies or after hematopoietic stem cell transplantation

Journal of Pediatric Hematology/Oncology

Volumn 34, Issue 6, 2012, Pages 442-449

  Fazekas, Tamas ^a   Eickhoff, Philipp ^a   Rauch, Margit ^b   Verdianz, Maria ^b   Attarbaschi, Andishe ^a   Dworzak, Michael ^a   Peters, Christina ^a   Hammer, Karin ^a   Vecsei, Andreas ^a   Pötschger, Ulrike ^b   Lion, Thomas ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b CHILDREN'S CANCER RESEARCH INSTITUTE   (Austria)

Author keywords

immunosuppression; respiratory fluid; viral infection

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADENOVIRUS INFECTION; ADULT; BOCAVIRUS INFECTION; CHILD; CHRONIC LEUKEMIA; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOCOMPROMISED PATIENT; INFLUENZA; LOWER RESPIRATORY TRACT INFECTION; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORBIDITY; PARAINFLUENZA VIRUS 1; PARAINFLUENZA VIRUS 2; PARAINFLUENZA VIRUS 3; PARAINFLUENZA VIRUS INFECTION; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY SYNCYTIAL VIRUS INFECTION; REVIEW; RHINOVIRUS INFECTION; SCHOOL CHILD; SCREENING TEST; UPPER RESPIRATORY TRACT INFECTION; VIRUS DETECTION; VIRUS INFECTION;

ADOLESCENT; AUSTRIA; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOCOMPROMISED HOST; INFANT; MALE; NEOPLASMS; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; RESPIRATORY TRACT INFECTIONS; RISK FACTORS; SURVIVAL RATE; VIRUS DISEASES; VIRUSES;

EID: 84864376648     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3182580bc8     Document Type: Review

References (41)

1. Ebner K, Suda M, Watzinger F, et al. Molecular detection andquantitative analysis of the entire spectrum of humanadenoviruses by a two-reaction real-time PCR assay. J ClinMicrobiol. 2005;43:3049-3053.
2. Kim YJ, Boeckh M, Englund JA. Community respiratory virusinfections in immunocompromised patients: Hematopoieticstem cell and solid organ transplant recipients, and individualswith human immunodeficiency virus infection. Semin RespirCrit Care Med. 2007;28:222-242.
3. Mu? ller A, Klinkenberg D, Vehreschild J, et al. Low prevalenceof human metapneumovirus and human bocavirus in adultimmunocompromised high risk patients suspected to sufferfrom Pneumocystis pneumonia. J Infect. 2009;58:227-231.
4. Cha? vez-Bueno S, Meji?as A, Merryman RA, et al. Intravenouspalivizumab and ribavirin combination for respiratory syncytialvirus disease in high-risk pediatric patients. Infect Dis J.2007;26:1089-1093.
5. El Saleeby CM, Somes GW, DeVincenzo JP, et al. Risk factorsfor severe respiratory syncytial virus disease in children withcancer: The importance of lymphopenia and young age.Pediatrics. 2008;121:235-243.
6. Martino R, Porras RP, Rabella N, et al. Prospective study ofthe incidence, clinical features, and outcome of symptomaticupper and lower respiratory tract infections by respiratoryviruses in adult recipients of hematopoietic stem cell transplantsfor hematologic malignancies. Biol Blood MarrowTransplant. 2005;11:781-796.
7. Nichols WG, Guthrie KA, Corey L, et al. Influenza infectionsafter hematopoietic stem cell transplantation: Risk factors,mortality, and the effect of antiviral therapy. Clin Infect Dis.2004;39:1300-1306.
8. Resch B, Gusenleitner W, Mu? ller WD, et al. Observationalstudy of respiratory syncytial virus-associated hospitalizationsand use of palivizumab in premature infants aged 29-32 weeks.Eur J Clin Microbiol Infect Dis. 2006;25:120-122.
9. Boeckh M, Berrey MM, Bowden RA, et al. Phase 1 evaluationof the respiratory syncytial virus-specific monoclonal antibodypalivizumab in recipients of hematopoietic stem cell transplants.J Infect Dis. 2001;184:350-354.
10. Greer RM, McErlean P, Arden KE, et al. Do rhinovirusesreduce the probability of viral co-detection during acuterespiratory tract infections? J Clin Virol. 2009;45:10-15.
11. Gutman JA, Peck AJ, Kuypers J, et al. Rhinovirus as a causeof fatal lower respiratory tract infection in adult stem celltransplantation patients: A report of two cases. Bone MarrowTransplant. 2007;40:809-811.
12. Gerna G, Piralla A, Rovida F, et al. Correlation of rhinovirusload in the respiratory tract and clinical symptoms inhospitalized immunocompetent and immunocompromisedpatients. J Med Virol. 2009;81:1498-1507.
13. Micha? lek J, Horvath R. High incidence of Epstein-Barr virus,cytomegalovirus and human herpesvirus 6 infections in childrenwith cancer. BMC Pediatr. 2002;2:1. Epub 2002 Jan 10.
14. Whimbey E, Champlin RE, Couch RB, et al. Communityrespiratory virus infections among hospitalized adult bonemarrow transplant recipients. Clin Infect Dis. 1996;22:778-782.
15. Erard V, Chien JW, Kim HW, et al. Airflow decline aftermyeloablative allogeneic hematopoietic cell transplantation: Therole of community respiratory viruses. JID. 2006;193:1619-1625.
16. Hall CB, Powell KR, MacDonald NE, et al. Respiratorysyncytial viral infection in children with compromised immunefunction. N Engl J Med. 1986;315:77-781.
17. Koskenvuo M, Mo? tto? nen M, Rahiala J, et al. Respiratory viralinfections in children with leukemia. Pediatr Infect Dis J. 2008;27:974-980.
18. Small TN, Casson A, Malak SF, et al. Respiratory syncytialvirus infection following hematopoietic stem cell transplantation.Bone Marrow Transplant. 2002;29:321-327.
19. Hakim H, Flynn PM, Knapp KM, et al. Etiology and clinicalcourse of febrile neutropenia in children with cancer. J PediatrHematol Oncol. 2009;31:623-629.
20. Sung L, Gamis A, Alonzo TA, et al. Infections and associationwith different intensity of chemotherapy in children with acutemyeloid leukemia. Cancer. 2009;115:1100-1108.
21. Christensen MS, Nielsen LP, Hasle H. Few but severe viralinfections in children with cancer: A prospective RT-PCR andPCR-based 12-month study. Pediatr Blood Cancer. 2005;45:945-951.
22. Lion T, Kosulin K, Landlinger C, et al. Monitoring ofadenovirus load in stool by real-time PCR permits earlydetection of impending invasive infection in patients afterallogeneic stem cell transplantation. Leukemia. 2010;24:706-714.
23. Kuypers J, Campbell AP, Cent A, et al. Comparison ofconventional and molecular detection of respiratory viruses inhematopoietic cell transplant recipients. Transpl Infect Dis.2009;11:298-303.
24. Torres JP, Gomez AM, Khokhar S, et al. Respiratory syncytialvirus (RSV) RNA loads in peripheral blood correlates withdisease severity in mice. Respir Res. 2010;11:125.
25. Haynes LM, Caidi H, Radu GU, et al. Therapeutic monoclonalantibody treatment targeting respiratory syncytial virus(RSV) G protein mediates viral clearance and reduces thepathogenesis of RSV infection in BALB/c mice. J Infect Dis.2009;200:439-447.
26. Debur MC, Vidal LR, Stroparo E, et al. Human metapneumovirusinfection in hematopoietic stem cell transplantrecipients. Transpl Infect Dis. 2010;12:173-179.
27. Boeckh M. The challenge of respiratory virus infections inhematopoietic cell transplant recipients. Br J Haematol.2008;143:455-467.
28. Lion T, Baumgartinger R, Watzinger F, et al. Molecularmonitoring of adenovirus in peripheral blood after allogeneicbone marrow transplantation permits early diagnosis ofdisseminated disease. Blood. 2003;102:1114-1120.
29. Peck AJ, Englund JA, Kuypers J, et al. Respiratory virusinfection among hematopoietic cell transplant recipients:evidence for asymptomatic parainfluenza virus infection.Blood. 2007;110:1681-1688.
30. Watzinger F, Ebner K, Lion T. Detection and monitoring ofvirus infections by real-time PCR. Mol Aspects Med. 2006;27: 254-298.
31. Arden KE, Faux CE, O'Neill NT, et al. Molecular characterizationand distinguishing features of a novel human rhinovirus(HRV) C, HRVC-QCE, detected in children with fever, coughand wheeze during 2003. J Clin Virol. 2010;47:219-223.
32. Watzinger F, Suda M, Preuner S, et al. Real-time quantitativePCR assays for detection and monitoring of pathogenic humanviruses in immunosuppressed pediatric patients. J Clin Microbiol.2004;42:5189-5198.
33. Khanna N, Widmer AF, Decker M, et al. Respiratorysyncytial virus infection in patients with hematologicaldiseases: Single-center study and review of the literature. ClinInfect Dis. 2008;46:402-412.
34. Englund JA, Piedra PA, Whimbey E. Prevention and treatmentof respiratory syncytial virus and parainfluenza viruses inimmunocompromised patients. Am J Med. 1997;102(3A):61-70.
35. Ulbrandt ND, Ji H, Patel NK, et al. Isolation and characterizationof monoclonal antibodies which neutralize human metapneumovirusin vitro and in vivo. J Virol. 2006;80:7799-7806.
36. Likos AM, Kelvin DJ, Cameron CM, et al. Influenza viremiaand the potential for blood-borne transmission. Transfusion.2007;47:1080-1088.
37. Anak S, Atay D, Unuvar A, et al. Respiratory syncytial virusinfection outbreak among pediatric patients with oncologicdiseases and/or BMT. Pediatr Pulmonol. 2010;45:307-311.
38. Avetisyan G, Mattsson J, Sparrelid E, et al. Respiratorysyncytial virus infection in recipients of allogeneic stem-celltransplantation: A retrospective study of the incidence, clinicalfeatures, and outcome. Transplantation. 2009;88:1222-1226.
39. Chemaly RF, Ghosh S, Bodey GP, et al. Respiratory viralinfections in adults with hematologic malignancies and humanstem cell transplantation recipients: A retrospective study at amajor cancer center. Medicine (Baltimore). 2006;85:278-287.
40. Ison MG, Hayden FG. Viral infections in immunocompromisedpatients: What's new with respiratory viruses? Curr OpinInfect Dis. 2002;15:355-367.
41. Ison MG, Hayden FG, Kaiser L, et al. Rhinovirus infections inhematopoietic stem cell transplant recipients with pneumonia.Clin Infect Dis. 2003;36:1139-1143.